These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2381875)
1. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner. Nouel D; Dubuc I; Kitabgi P; Costentin J Peptides; 1990; 11(3):551-5. PubMed ID: 2381875 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of apomorphine-induced yawning and penile erection by neurotensin. Nouel D; Costentin J Peptides; 1991; 12(4):755-9. PubMed ID: 1788138 [TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats. Bousselmame R; Eustache M; Michael-Titus A; Costentin J Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043 [TBL] [Abstract][Full Text] [Related]
4. Locomotor effects of [D-Trp11]neurotensin and dopamine transmission in rats. Nouel D; Costentin J Eur J Pharmacol; 1994 Mar; 254(3):263-9. PubMed ID: 8013561 [TBL] [Abstract][Full Text] [Related]
5. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice. Van Kemmel FM; Dubuc I; Bourdel E; Fehrentz JA; Martinez J; Costentin J Neurosci Lett; 1996 Oct; 217(1):58-60. PubMed ID: 8905739 [TBL] [Abstract][Full Text] [Related]
7. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor. Michael-Titus A; Preterre P; Giros B; Costentin J J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843 [TBL] [Abstract][Full Text] [Related]
8. Tolerance to the hypothermic but not to the analgesic effect of [D-Trp11]neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats. Dubuc I; Pain C; Suaudeau C; Costentin J Peptides; 1994; 15(2):303-7. PubMed ID: 8008636 [TBL] [Abstract][Full Text] [Related]
9. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Michael-Titus A; Dourmap N; Costentin J; Schwartz JC Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928 [TBL] [Abstract][Full Text] [Related]
10. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Ford AP; Marsden CA Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584 [TBL] [Abstract][Full Text] [Related]
11. Involvement of dopamine in the central effect of neurotensin on intestinal motility in rats. Fargeas MJ; Fioramonti J; Bueno L Peptides; 1990; 11(6):1169-73. PubMed ID: 2087439 [TBL] [Abstract][Full Text] [Related]
12. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro. Adjroud O J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405 [TBL] [Abstract][Full Text] [Related]
13. Neurotensin and neurotensin analogues modify the effects of chronic neuroleptic administration in the rat. Stoessl AJ; Szczutkowski E Brain Res; 1991 Sep; 558(2):289-95. PubMed ID: 1685934 [TBL] [Abstract][Full Text] [Related]
14. Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J). Michael-Titus A; Dourmap N; Caline H; Costentin J; Schwartz JC Neuropharmacology; 1989 Feb; 28(2):117-22. PubMed ID: 2716968 [TBL] [Abstract][Full Text] [Related]
15. Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan. Khallouk-Bousselmame R; Costentin J Eur Neuropsychopharmacol; 1994 Jun; 4(2):137-43. PubMed ID: 7919943 [TBL] [Abstract][Full Text] [Related]
17. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus. Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber JC; Fulcrand H; Doulut S; Rodriguez M; Martinez J Neurosci Lett; 1992 Aug; 142(2):200-4. PubMed ID: 1454216 [TBL] [Abstract][Full Text] [Related]
18. [D-TRP11]-neurotensin, unlike alpha-flupenthixol, may not block amphetamine-induced hyperactivity in rats. Sahgal A; Keith AB; Lloyd S; Edwardson JA Neuropharmacology; 1989 Mar; 28(3):283-9. PubMed ID: 2725853 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat. Rivest R; St-Pierre S; Jolicoeur FB Neuropharmacology; 1991 Jan; 30(1):47-52. PubMed ID: 1904561 [TBL] [Abstract][Full Text] [Related]
20. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]